KARX vs YCBD: stock comparison and AI forecast
Karbon-X Corp. (KARX) and Cbdmd, Inc. (YCBD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
KARX Karbon-X Corp.
- Price
- $0.15 -16.7% · 6M
- Market Cap
- $16M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
YCBD Cbdmd, Inc.
- Price
- $0.39 -55.4% · 6M
- Market Cap
- $4M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- KARX is 3.8 times larger than YCBD by market capitalization ($16M against $4M).
- Over the last six months KARX returned -16.7% and YCBD -55.4%.
- YCBD turns -13.8% of its revenue into net income, against -53.0% for KARX.
- Both companies share the SEC industry classification Perfumes, Cosmetics & Other Toilet Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | KARX | YCBD |
|---|---|---|
| Market Cap | $16M | $4M |
| P/B Ratio | – | 0.53x |
| EPS | $-0.10 | – |
| Book Value/Share | – | $0.73 |
| Revenue/Share | – | $1.87 |
| FCF/Share | – | $-0.22 |
Profitability & Margins
| Metric | KARX | YCBD |
|---|---|---|
| ROE | – | -35.2% |
| ROA | -205.4% | -22.0% |
| ROIC | – | -28.8% |
| Gross Margin | 3.0% | 57.7% |
| Operating Margin | -34.4% | -13.9% |
| Net Margin | -53.0% | -13.8% |
| EBT Margin | -44.3% | -13.8% |
| Tax Rate | 0.0% | – |
Financial Health
| Metric | KARX | YCBD |
|---|---|---|
| Current Ratio | 0.36x | 2.50x |
| Quick Ratio | 0.30x | 1.37x |
| D/E Ratio | – | 0.60x |
| Financial Leverage | – | 1.60x |
| Interest Coverage | 2.5x | -345.2x |
| Working Capital | -$7M | $5M |
Cash Flow
| Metric | KARX | YCBD |
|---|---|---|
| Operating Cash Flow | -$6M | -$2M |
| Free Cash Flow | – | -$2M |
| Capital Spending | – | -$190K |
| FCF/Sales | – | -11.5% |
| CapEx/Sales | – | 0.9% |
Operational Efficiency
| Metric | KARX | YCBD |
|---|---|---|
| Asset Turnover | – | 1.59x |
| Receivables Turnover | – | 22.6x |
| Inventory Turnover | 83.5x | 2.6x |
| Fixed Assets Turnover | – | 62.5x |
| Days Sales Outstanding | – | 16 days |
| Days Inventory | 4 days | 143 days |
| Payables Period | 15 days | 61 days |
| Cash Conversion Cycle | – | 97 days |
Income Statement
| Metric | KARX | YCBD |
|---|---|---|
| Total Revenue | – | $21M |
| Operating Income | -$10M | -$3M |
| Net Income | -$16M | -$3M |
| Cost of Goods Sold | $60M | $9M |
Dividend & Shareholder Information
| Metric | KARX | YCBD |
|---|---|---|
| Shares Outstanding | 109M | 11M |
KARX vs YCBD: stock comparison and AI forecast
Which is bigger, KARX or YCBD?
KARX is 3.8 times larger than YCBD by market capitalization ($16M against $4M).
Which stock performed better over the last six months, KARX or YCBD?
Over the last six months KARX returned -16.7% and YCBD -55.4%.
Which one does Intratio's AI model rank higher, KARX or YCBD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.